Charah Solutions, Inc. (CHRA) Stock Competitors & Peer Comparison
See (CHRA) competitors and their performances in Stock Market.
Peer Comparison Table: Waste Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHRA | $5.96 | +0.17% | 20.3M | -0.15 | -$38.80 | N/A |
| WM | $220.40 | +0.63% | 88.5B | 31.88 | $6.91 | +1.60% |
| RSG | $210.04 | +1.02% | 64.6B | 30.18 | $6.96 | +1.16% |
| WCN | $155.22 | +0.82% | 39.4B | 37.86 | $4.10 | +0.87% |
| GFLU | $70.30 | +4.32% | 25B | -91.90 | -$0.77 | N/A |
| CLH | $283.03 | -1.35% | 14.9B | 38.37 | $7.37 | N/A |
| GFL | $35.51 | -0.81% | 12.3B | 96.00 | $0.37 | +0.18% |
| SRCL | $61.98 | +0.83% | 5.8B | 158.92 | $0.39 | N/A |
| CWST | $85.90 | +2.69% | 5.4B | 780.91 | $0.11 | N/A |
| NVRI | $19.30 | -2.03% | 1.6B | -9.43 | -$2.05 | +77.66% |
Stock Comparison
CHRA vs WM Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WM has a market cap of 88.5B. Regarding current trading prices, CHRA is priced at $5.96, while WM trades at $220.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WM's P/E ratio is 31.88. In terms of profitability, CHRA's ROE is +20.59%, compared to WM's ROE of +0.29%. Regarding short-term risk, CHRA is less volatile compared to WM. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WM's competition here
CHRA vs RSG Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, RSG has a market cap of 64.6B. Regarding current trading prices, CHRA is priced at $5.96, while RSG trades at $210.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas RSG's P/E ratio is 30.18. In terms of profitability, CHRA's ROE is +20.59%, compared to RSG's ROE of +0.18%. Regarding short-term risk, CHRA is less volatile compared to RSG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check RSG's competition here
CHRA vs WCN Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WCN has a market cap of 39.4B. Regarding current trading prices, CHRA is priced at $5.96, while WCN trades at $155.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WCN's P/E ratio is 37.86. In terms of profitability, CHRA's ROE is +20.59%, compared to WCN's ROE of +0.13%. Regarding short-term risk, CHRA is less volatile compared to WCN. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WCN's competition here
CHRA vs GFLU Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFLU has a market cap of 25B. Regarding current trading prices, CHRA is priced at $5.96, while GFLU trades at $70.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFLU's P/E ratio is -91.90. In terms of profitability, CHRA's ROE is +20.59%, compared to GFLU's ROE of N/A. Regarding short-term risk, CHRA is less volatile compared to GFLU. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFLU's competition here
CHRA vs CLH Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CLH has a market cap of 14.9B. Regarding current trading prices, CHRA is priced at $5.96, while CLH trades at $283.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CLH's P/E ratio is 38.37. In terms of profitability, CHRA's ROE is +20.59%, compared to CLH's ROE of +0.14%. Regarding short-term risk, CHRA is less volatile compared to CLH. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CLH's competition here
CHRA vs GFL Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFL has a market cap of 12.3B. Regarding current trading prices, CHRA is priced at $5.96, while GFL trades at $35.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFL's P/E ratio is 96.00. In terms of profitability, CHRA's ROE is +20.59%, compared to GFL's ROE of +0.03%. Regarding short-term risk, CHRA is less volatile compared to GFL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFL's competition here
CHRA vs SRCL Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SRCL has a market cap of 5.8B. Regarding current trading prices, CHRA is priced at $5.96, while SRCL trades at $61.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SRCL's P/E ratio is 158.92. In terms of profitability, CHRA's ROE is +20.59%, compared to SRCL's ROE of -0.01%. Regarding short-term risk, CHRA is less volatile compared to SRCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SRCL's competition here
CHRA vs CWST Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CWST has a market cap of 5.4B. Regarding current trading prices, CHRA is priced at $5.96, while CWST trades at $85.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CWST's P/E ratio is 780.91. In terms of profitability, CHRA's ROE is +20.59%, compared to CWST's ROE of +0.00%. Regarding short-term risk, CHRA is less volatile compared to CWST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CWST's competition here
CHRA vs NVRI Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NVRI has a market cap of 1.6B. Regarding current trading prices, CHRA is priced at $5.96, while NVRI trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NVRI's P/E ratio is -9.43. In terms of profitability, CHRA's ROE is +20.59%, compared to NVRI's ROE of +0.37%. Regarding short-term risk, CHRA is less volatile compared to NVRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NVRI's competition here
CHRA vs HCCI Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HCCI has a market cap of 1.1B. Regarding current trading prices, CHRA is priced at $5.96, while HCCI trades at $45.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HCCI's P/E ratio is 14.22. In terms of profitability, CHRA's ROE is +20.59%, compared to HCCI's ROE of +0.22%. Regarding short-term risk, CHRA is less volatile compared to HCCI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HCCI's competition here
CHRA vs HSC Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HSC has a market cap of 729.6M. Regarding current trading prices, CHRA is priced at $5.96, while HSC trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HSC's P/E ratio is -5.08. In terms of profitability, CHRA's ROE is +20.59%, compared to HSC's ROE of -0.70%. Regarding short-term risk, CHRA is less volatile compared to HSC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HSC's competition here
CHRA vs MEG Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, MEG has a market cap of 565.7M. Regarding current trading prices, CHRA is priced at $5.96, while MEG trades at $15.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas MEG's P/E ratio is -120.31. In terms of profitability, CHRA's ROE is +20.59%, compared to MEG's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to MEG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check MEG's competition here
CHRA vs PESI Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, PESI has a market cap of 178.8M. Regarding current trading prices, CHRA is priced at $5.96, while PESI trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas PESI's P/E ratio is -12.19. In terms of profitability, CHRA's ROE is +20.59%, compared to PESI's ROE of -0.34%. Regarding short-term risk, CHRA is less volatile compared to PESI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check PESI's competition here
CHRA vs YDDL Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, YDDL has a market cap of 124.2M. Regarding current trading prices, CHRA is priced at $5.96, while YDDL trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas YDDL's P/E ratio is 11.78. In terms of profitability, CHRA's ROE is +20.59%, compared to YDDL's ROE of +0.36%. Regarding short-term risk, CHRA is less volatile compared to YDDL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check YDDL's competition here
CHRA vs ESGL Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ESGL has a market cap of 80.1M. Regarding current trading prices, CHRA is priced at $5.96, while ESGL trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ESGL's P/E ratio is -31.50. In terms of profitability, CHRA's ROE is +20.59%, compared to ESGL's ROE of -0.06%. Regarding short-term risk, CHRA is less volatile compared to ESGL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ESGL's competition here
CHRA vs LICY Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LICY has a market cap of 29.9M. Regarding current trading prices, CHRA is priced at $5.96, while LICY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LICY's P/E ratio is -0.15. In terms of profitability, CHRA's ROE is +20.59%, compared to LICY's ROE of -0.41%. Regarding short-term risk, CHRA is less volatile compared to LICY. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LICY's competition here
CHRA vs QRHC Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, QRHC has a market cap of 26.6M. Regarding current trading prices, CHRA is priced at $5.96, while QRHC trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas QRHC's P/E ratio is -3.71. In terms of profitability, CHRA's ROE is +20.59%, compared to QRHC's ROE of -0.18%. Regarding short-term risk, CHRA is less volatile compared to QRHC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check QRHC's competition here
CHRA vs AMBI Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AMBI has a market cap of 24.4M. Regarding current trading prices, CHRA is priced at $5.96, while AMBI trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AMBI's P/E ratio is -44.00. In terms of profitability, CHRA's ROE is +20.59%, compared to AMBI's ROE of -0.02%. Regarding short-term risk, CHRA is less volatile compared to AMBI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AMBI's competition here
CHRA vs ENGS Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ENGS has a market cap of 23.2M. Regarding current trading prices, CHRA is priced at $5.96, while ENGS trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ENGS's P/E ratio is -7.09. In terms of profitability, CHRA's ROE is +20.59%, compared to ENGS's ROE of +0.28%. Regarding short-term risk, CHRA is less volatile compared to ENGS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ENGS's competition here
CHRA vs LNZA Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LNZA has a market cap of 14.5M. Regarding current trading prices, CHRA is priced at $5.96, while LNZA trades at $6.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LNZA's P/E ratio is -0.46. In terms of profitability, CHRA's ROE is +20.59%, compared to LNZA's ROE of -12.68%. Regarding short-term risk, CHRA is less volatile compared to LNZA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LNZA's competition here
CHRA vs AQMS Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AQMS has a market cap of 11.8M. Regarding current trading prices, CHRA is priced at $5.96, while AQMS trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AQMS's P/E ratio is -0.57. In terms of profitability, CHRA's ROE is +20.59%, compared to AQMS's ROE of -1.85%. Regarding short-term risk, CHRA is less volatile compared to AQMS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AQMS's competition here
CHRA vs AWX Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AWX has a market cap of 9.7M. Regarding current trading prices, CHRA is priced at $5.96, while AWX trades at $2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AWX's P/E ratio is 17.79. In terms of profitability, CHRA's ROE is +20.59%, compared to AWX's ROE of +0.02%. Regarding short-term risk, CHRA is less volatile compared to AWX. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AWX's competition here
CHRA vs CHNR Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CHNR has a market cap of 5.3M. Regarding current trading prices, CHRA is priced at $5.96, while CHNR trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CHNR's P/E ratio is -30.14. In terms of profitability, CHRA's ROE is +20.59%, compared to CHNR's ROE of -0.01%. Regarding short-term risk, CHRA is less volatile compared to CHNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CHNR's competition here
CHRA vs GWAV Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GWAV has a market cap of 2.8M. Regarding current trading prices, CHRA is priced at $5.96, while GWAV trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GWAV's P/E ratio is 0.02. In terms of profitability, CHRA's ROE is +20.59%, compared to GWAV's ROE of -0.89%. Regarding short-term risk, CHRA is less volatile compared to GWAV. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GWAV's competition here
CHRA vs DXST Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, DXST has a market cap of 2.6M. Regarding current trading prices, CHRA is priced at $5.96, while DXST trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas DXST's P/E ratio is -8.10. In terms of profitability, CHRA's ROE is +20.59%, compared to DXST's ROE of -0.04%. Regarding short-term risk, CHRA is less volatile compared to DXST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check DXST's competition here
CHRA vs CDTG Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CDTG has a market cap of 1.6M. Regarding current trading prices, CHRA is priced at $5.96, while CDTG trades at $3.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CDTG's P/E ratio is -0.16. In terms of profitability, CHRA's ROE is +20.59%, compared to CDTG's ROE of -0.29%. Regarding short-term risk, CHRA is less volatile compared to CDTG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CDTG's competition here
CHRA vs CVA Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CVA has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while CVA trades at $20.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CVA's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to CVA's ROE of -0.08%. Regarding short-term risk, CHRA is less volatile compared to CVA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CVA's competition here
CHRA vs ECOL Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOL has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOL trades at $47.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOL's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOL's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to ECOL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ECOL's competition here
CHRA vs SMED Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SMED has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while SMED trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SMED's P/E ratio is 36.46. In terms of profitability, CHRA's ROE is +20.59%, compared to SMED's ROE of +0.34%. Regarding short-term risk, CHRA is less volatile compared to SMED. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SMED's competition here
CHRA vs NES Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NES has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while NES trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NES's P/E ratio is -1.32. In terms of profitability, CHRA's ROE is +20.59%, compared to NES's ROE of -0.29%. Regarding short-term risk, CHRA is less volatile compared to NES. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NES's competition here
CHRA vs ECOLW Comparison June 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOLW has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOLW trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOLW's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOLW's ROE of +0.01%. Regarding short-term risk, CHRA and ECOLW have similar daily volatility (0.00).Check ECOLW's competition here